Dead Bat in Glacier National Park Tests Positive for Park’s First-Ever Case of White-Nose Syndrome

Researchers at Glacier National Park have recently confirmed the presence of white-nose syndrome (WNS) in a brown bat found in the park, marking a troubling development in the ongoing battle against this deadly disease. Samples collected from the park’s east side in June revealed the presence of the fungus Pseudogymnoascus destructans, the causative agent of WNS. This represents the first documented case of the disease within Glacier County and the national park itself.

White-nose syndrome, which primarily affects hibernating bats, has been labelled a growing concern across North America by health authorities including the Centres for Disease Control and Prevention (CDC). The syndrome causes alarming declines in bat populations as the fungus attacks the vulnerable areas of bats’ bodies such as their wings, nose, and ears. Consequently, this leads to severe depletion of fat reserves, resulting in dehydration, starvation, and often death.

In response to the rising threat posed by WNS, a collaborative effort has been initiated between the Glacier National Park Conservancy, the Natural Resource Fund Source, and the National Fish and Wildlife Foundation. This partnership has worked towards tracking the park’s diverse bat population, which includes ten different species, since 2011.

In an innovative step towards combatting this epidemic, Glacier National Park has been actively researching a potential vaccine for WNS. Since the start of 2024, the park’s researchers have undertook a significant trial, gathering a total of 529 bats for assessment. Of these, 265 bats received the experimental vaccine, while the remaining 264 were administered a placebo. All bats have been tagged for ongoing monitoring, with researchers now poised to evaluate the efficacy of the vaccine as the bats emerge from hibernation in spring.

The intention behind this research is to compare the survival rates of the two groups—vaccinated and those who received the placebo. Such findings could be pivotal in determining whether the vaccine can effectively reduce the mortality caused by white-nose syndrome.

A decline in bat populations within Glacier National Park can have far-reaching implications for local ecosystems. Bats play a crucial role in controlling insect populations, indicating that a significant reduction in their numbers may lead to an imbalanced ecosystem. Furthermore, other wildlife such as raptors and weasels that depend on bats for food would also be adversely affected.

Although transmission of WNS primarily occurs through bat-to-bat contact, the resilience of the fungus is concerning as it can survive in the environment for several years, thereby posing a continual threat to new bat arrivals. Importantly, while WNS does not affect humans or domestic animals, there is a cautionary note for outdoor enthusiasts. It is essential for individuals to take precautions to prevent spreading the fungus; this entails thorough decontamination of clothing, footwear, and equipment after visiting bat habitats or caves.

Official guidelines from the U.S. Fish and Wildlife Service strongly discourage the handling of bats to prevent further transmission of the disease. As white-nose syndrome was first identified in New York State in 2006, it has now spread to a staggering 42 states and nine provinces in Canada, underscoring the urgent need for effective control measures.

The ongoing research at Glacier National Park highlights a proactive approach to wildlife preservation, aiming to bolster bat populations in the face of mounting environmental threats. As scientists continue their vital work, it remains essential for the public to remain informed and adopt responsible practices to protect these crucial species and the ecosystems they support.